Indacaterol
Back to searchMolecule Structure
Scientific Name
Indacaterol
Description of the Drug
Indacaterol is an inhaled long-acting beta-2 adrenergic agonist used to relax bronchial smooth muscle and improve symptoms and airflow obstruction caused by Chronic Obstructive Pulmonary Disease (COPD) and moderate to severe asthma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05039
http://www.drugbank.ca/drugs/DB05039
Brand Name(s)
Not Available
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL48098 | |
| PharmGKB | PA165958348 | |
| Human Metabolome Database | HMDB0015608 | |
| DrugBank | DB05039 | |
| PubChem: Thomson Pharma | 15126362 | 14805326 |
| PubChem | 6918554 | |
| LINCS | LSM-45506 | |
| Nikkaji | J2.407.733K | |
| BindingDB | 50318159 | |
| EPA CompTox Dashboard | DTXSID90185198 | |
| DrugCentral | 4183 | |
| ChemicalBook | CB72566367 | CB82512068 |
| Guide to Pharmacology | 7455 | |
| rxnorm | INDACATEROL MALEATE | INDACATEROL |
| ChEBI | 68575 | |
| ZINC | ZINC000035801098 |
